You are here

Article info

Article menu
Case Reports: Rare disease
Case of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) due to Legionella pneumonia

Authors

  • Satoko Kageyama Internal Medicine, Kosei General Hospital, Mihara, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Ruiko Hayashi Internal Medicine, Kosei General Hospital, Mihara, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Haruhito A Uchida Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanChronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Satoko Kageyama; satoko_21218{at}yahoo.co.jp
View Full Text

Citation

Kageyama S, Hayashi R, Uchida HA
Case of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) due to Legionella pneumonia
BMJ Case Reports CP 2022;15:e252994.

Publication history

  • Accepted December 18, 2022
  • First published December 30, 2022.
Online issue publication 
August 17, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.